Celecoxib
Celecoxib is a pharmaceutical drug with 365 clinical trials. Currently 24 active trials ongoing. Historical success rate of 78.8%.
Success Metrics
Based on 227 completed trials
Phase Distribution
Phase Distribution
80
Early Stage
134
Mid Stage
115
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
74.7%
227 of 304 finished
25.3%
77 ended early
24
trials recruiting
365
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain
99Tc-MDP Treatment for Knee Osteoarthritis
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Stony Brook Medicine Anti-Inflammatory Trial
Clinical Trials (365)
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain
99Tc-MDP Treatment for Knee Osteoarthritis
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Stony Brook Medicine Anti-Inflammatory Trial
Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Opioid-Free Pain Protocol After Shoulder Arthroplasty
Window of Opportunity Study Targeting the Inflammatory Milieu
Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer
The Seven Trial: Exploiting the Unfolded Protein Response
LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 365